Mark Anderson

Person

Plymouth Meeting, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
EGFR and c-Met fibronectin type III domain binding molecules
- Patent number 10,954,284
- Issue date Mar 23, 2021
- Janssen Biotech, Inc.
- Mark Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cysteine engineered fibronectin type III domain binding molecules
- Patent number 10,662,235
- Issue date May 26, 2020
- Janssen Biotech, Inc.
- Mark Anderson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
EGFR and C-Met fibronectin type III domain binding molecules
- Patent number 9,725,497
- Issue date Aug 8, 2017
- Janssen Biotech, Inc.
- Mark Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic uses for an aminosterol compound
- Patent number 8,987,236
- Issue date Mar 24, 2015
- Ohr Pharmaceutical, Inc.
- Michael Zasloff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic uses for aminosterol compounds
- Patent number 7,410,959
- Issue date Aug 12, 2008
- Genaera Corporation
- Michael Zasloff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for use of defensin
- Patent number 6,399,370
- Issue date Jun 4, 2002
- The Trustees of the University of Pennsylvania
- James M. Wilson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of inhibiting profileration of cells by administering an ami...
- Patent number 5,795,885
- Issue date Aug 18, 1998
- Magainin Pharmaceuticals Inc.
- Michael Zasloff
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
EGFR and C-Met Fibronectin Type III Domain Binding Molecules
- Publication number 20210206825
- Publication date Jul 8, 2021
- JANSSEN BIOTECH, INC.
- Mark Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYSTEINE ENGINEERED FIBRONECTIN TYPE III DOMAIN BINDING MOLECULES
- Publication number 20200325210
- Publication date Oct 15, 2020
- JANSSEN BIOTECH, INC.
- Mark Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cysteine Engineered Fibronectin Type III Domain Binding Molecules
- Publication number 20170362301
- Publication date Dec 21, 2017
- JANSSEN BIOTECH, INC.
- Mark Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EGFR and C-Met Fibronectin Type III Domain Binding Molecules
- Publication number 20170305997
- Publication date Oct 26, 2017
- JANSSEN BIOTECH, INC.
- Mark Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Therapeutic Uses for an Aminosterol Compound
- Publication number 20130281419
- Publication date Oct 24, 2013
- Michael Zasloff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Therapeutic Uses for Aminosterol Compounds
- Publication number 20090105204
- Publication date Apr 23, 2009
- Michael Zasloff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Therapeutic Uses For Aminosterol Compounds
- Publication number 20080221075
- Publication date Sep 11, 2008
- Michael Zasloff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method for stimulation of defensin production
- Publication number 20020076393
- Publication date Jun 20, 2002
- Magainin Pharmaceuticals, Inc.
- Pascale Fehlbaum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Mark Anderson

Person

Patents Grantslast 30 patents

EGFR and c-Met fibronectin type III domain binding molecules

Cysteine engineered fibronectin type III domain binding molecules

EGFR and C-Met fibronectin type III domain binding molecules

Therapeutic uses for an aminosterol compound

Therapeutic uses for aminosterol compounds

Compositions and methods for use of defensin

Method of inhibiting profileration of cells by administering an ami...

Patents Applicationslast 30 patents

EGFR and C-Met Fibronectin Type III Domain Binding Molecules

CYSTEINE ENGINEERED FIBRONECTIN TYPE III DOMAIN BINDING MOLECULES

Cysteine Engineered Fibronectin Type III Domain Binding Molecules

EGFR and C-Met Fibronectin Type III Domain Binding Molecules

Therapeutic Uses for an Aminosterol Compound

Therapeutic Uses for Aminosterol Compounds

Therapeutic Uses For Aminosterol Compounds

Method for stimulation of defensin production